Published in J Prev Med Hyg on December 01, 2014
Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation. Front Microbiol (2016) 0.82
Fecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic Review. Front Microbiol (2016) 0.75
Operating room environment and surgical site infections in arthroplasty procedures. J Prev Med Hyg (2016) 0.75
Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii. BMC Microbiol (2016) 0.75
Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus. BMC Complement Altern Med (2017) 0.75
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (1997) 18.24
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother (1997) 17.36
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA (2008) 7.60
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 7.52
Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med (2008) 5.92
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis (2001) 5.28
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev (2010) 4.76
Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 4.48
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis (2012) 4.20
Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med (2002) 3.28
Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ (2008) 2.70
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev (2008) 2.69
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (2003) 2.51
Beta-lactam-specific resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1986) 2.41
Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep (1997) 2.40
Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet (1999) 2.30
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother (2003) 2.02
Efficacy of alcohol gel for removal of methicillin-resistant Staphylococcus aureus from hands of colonized patients. Infect Control Hosp Epidemiol (2015) 1.99
Meticillin resistant Staphylococcus aureus in the hospital. BMJ (2009) 1.90
Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. Clin Microbiol Infect (2011) 1.87
MRSA--the tip of the iceberg. Clin Microbiol Infect (2006) 1.81
Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother (2010) 1.80
Methicillin resistance in staphylococci. Lancet (1963) 1.75
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents (2011) 1.66
Survival of MRSA on sterile goods packaging. J Hosp Infect (2001) 1.58
Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center. J Clin Microbiol (2007) 1.44
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis (2009) 1.28
Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin Infect Dis (1998) 1.26
Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. J Clin Microbiol (2011) 1.16
Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections. PLoS One (2011) 1.16
Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect Dis (2001) 1.06
Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br J Surg (2008) 1.05
The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect (2001) 1.04
Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect (2007) 0.94
Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization symposium. Geneva, Switzerland, 29 November-2 December, 1995. Clin Infect Dis (1997) 0.94
Environmental monitoring programme in the cell therapy facility of a research centre: preliminary investigation. J Prev Med Hyg (2010) 0.93
Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. J Infect Chemother (2014) 0.93
Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital. Am J Infect Control (2011) 0.91
Surface disinfection: evaluation of the efficacy of a nebulization system spraying hydrogen peroxide. J Prev Med Hyg (2008) 0.90
Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital. Int J Antimicrob Agents (2014) 0.89
Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial. Infect Control Hosp Epidemiol (2014) 0.89
Hand contamination during routine care in medical wards: the role of hand hygiene compliance. J Med Microbiol (2013) 0.89
Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection (2014) 0.89
Promoting and sustaining a hospital-wide, multifaceted hand hygiene program resulted in significant reduction in health care-associated infections. Am J Infect Control (2012) 0.89
"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. Antimicrob Agents Chemother (2014) 0.88
Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK. J Antimicrob Chemother (2010) 0.86
Detection of glycopeptide resistance in Staphylococcus aureus. J Antimicrob Chemother (2001) 0.85
A new microbiological problem in intensive care units: environmental contamination by MRSA with reduced susceptibility to glycopeptides. Int J Hyg Environ Health (2007) 0.84
Multidrug-resistant Acinetobacter baumannii outbreak: an investigation of the possible routes of transmission. Public Health (2013) 0.84
Occurrence of potentially pathogenic bacteria on the hands of hospital patients before and after the introduction of patient hand disinfection. APMIS (2012) 0.83
Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J Clin Microbiol Infect Dis (2010) 0.82
Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus. Trends Microbiol (2009) 0.82
Hand hygiene in reducing transient flora on the hands of healthcare workers: an educational intervention. Indian J Med Microbiol (2015) 0.82
Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit. Infect Control Hosp Epidemiol (2015) 0.80
Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan. Int J Antimicrob Agents (2011) 0.80
[Surveillance and control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A GEIH-SEIMC and SEMPSPH consensus document]. Enferm Infecc Microbiol Clin (2008) 0.79
Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus. Med J Armed Forces India (2014) 0.79
Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospital. Microb Drug Resist (2014) 0.79
Screening and isolation for infection control. J Hosp Infect (2009) 0.79
Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles. Gynecol Oncol (2011) 1.46
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem (1999) 1.42
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology (2000) 1.34
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J (2001) 1.14
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. Br J Pharmacol (2008) 1.11
Specific tritium labeling of gangliosides at the 3-position of sphingosines. J Lipid Res (1981) 1.07
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf) (2011) 1.01
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia (2011) 1.00
Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus. J Prev Med Hyg (2006) 0.97
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res (2009) 0.96
New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers. Indian J Med Res (2013) 0.96
Carrier testing strategy in haemophilia A. Lancet (1986) 0.94
Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol (1977) 0.94
Environmental monitoring programme in the cell therapy facility of a research centre: preliminary investigation. J Prev Med Hyg (2010) 0.93
Intraventricular schwannoma. Childs Nerv Syst (1988) 0.93
Nitrous oxide pollution in operating theatres in relation to the type of leakage and the number of efficacious air exchanges per hour. J Prev Med Hyg (2006) 0.91
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J (2001) 0.91
Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy (2009) 0.91
Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences. J Prev Med Hyg (2012) 0.91
Fungal contamination in hospital environments. Infect Control Hosp Epidemiol (2006) 0.90
Effect of brain cortex phospholipids on adenylate-cyclase activity of mouse brain. J Neurochem (1978) 0.90
Surface disinfection: evaluation of the efficacy of a nebulization system spraying hydrogen peroxide. J Prev Med Hyg (2008) 0.90
The epidemiology of domestic injurious falls in a community dwelling elderly population: an outgrowing economic burden. Eur J Public Health (2009) 0.89
Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur Neurol (1980) 0.89
An experimental set-up to study carbon, water, and nitrate uptake rates by hydroponically grown plants. J Plant Nutr (1996) 0.89
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol (2013) 0.88
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains. Eur J Clin Microbiol Infect Dis (2007) 0.88
Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro. Biochem Mol Biol Int (1995) 0.88
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy). Vaccine (2009) 0.88
Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity. J Prev Med Hyg (2009) 0.86
Skin fibroblasts in Huntington's disease. N Engl J Med (1978) 0.86
Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol (1980) 0.86
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg (2014) 0.86
Investigation of organizational and hygiene features in dentistry: a pilot study. J Prev Med Hyg (2009) 0.86
[Relationship between settling microbial load and suspended microbial load in operating rooms]. Ann Ig (2001) 0.85
Correlative immunocytochemical and electron microscopic studies: identification of (entero)glucagon- somatostatin- and pancreatic polypeptide-like-containing cells in the human colon. Histochemistry (1981) 0.84
Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes. Life Sci (1978) 0.84
Multidrug-resistant Acinetobacter baumannii outbreak: an investigation of the possible routes of transmission. Public Health (2013) 0.84
Live attenuated influenza vaccine--a review. J Prev Med Hyg (2011) 0.83
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. Immunopharmacol Immunotoxicol (2000) 0.83
Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype. Tissue Antigens (1992) 0.83
The fate of tritium labeled GM1 ganglioside injected in mice. Pharmacol Res Commun (1979) 0.83
Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario. Vaccine (2009) 0.82
Operating theatre quality and prevention of surgical site infections. J Prev Med Hyg (2013) 0.81
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg (2014) 0.81
Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model. Epidemiol Infect (2008) 0.81
Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern? J Prev Med Hyg (2006) 0.80
Evaluation of contamination by blood aerosols produced during various healthcare procedures. J Hosp Infect (2008) 0.80
Environmental and personal monitoring of exposure to urban noise and community response. Eur J Epidemiol (1994) 0.80
Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccination. Eur J Clin Microbiol Infect Dis (2011) 0.80
Synthesis and applications of chitosan mercaptanes as heavy metal retention agent. Int J Biol Macromol (2001) 0.79
Altered proliferative kinetics in PHA-activated human T-lymphocytes treated with the anti-HLA class I monoclonal antibody 01.65. Cell Prolif (1992) 0.79
Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen. Vaccine (2009) 0.78
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. J Prev Med Hyg (2011) 0.78
Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus. Pharmacol Res Commun (1985) 0.78
A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. II: Human dynamic and imaging studies. J Nucl Med Allied Sci (1988) 0.78
Silver zeolite antimicrobial activity in aluminium heating, ventilation and air conditioning system ducts. J Prev Med Hyg (2008) 0.78
Interactions of GM1 ganglioside with crude rat brain neuronal membranes. J Neurochem (1980) 0.78
An improved procedure for the synthesis of 14C-labeled phosphatidylserine from cerebral phosphatidic acid. J Lipid Res (1980) 0.77
Virological investigation on aerosol from waste depuration plants. J Prev Med Hyg (2006) 0.77
Health care-acquired aspergillosis and air conditioning systems. J Prev Med Hyg (2009) 0.77
[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?]. Recenti Prog Med (2001) 0.77
The effect of acute ethanol administration on phosphorylcholine uptake and metabolism in rat liver slices. Farmaco Sci (1979) 0.77
The contribution of net synthesis and base-exchange reactions in phospholipid biosynthesis. Adv Exp Med Biol (1976) 0.77
Fertility in a i(Xq) Klinefelter patient: importance of XIST expression level determined by qRT-PCR in ruling out Klinefelter cryptic mosaicism as cause of oligozoospermia. Mol Hum Reprod (2008) 0.77
Endocrine cells of the colon in Hirschsprung's and control children. Virchows Arch A Pathol Anat Histol (1978) 0.77
Ontogeny and distribution of certain oendocrine cells in the human fetal large intestine. Histochemical and immunocytochemical studies. Cell Tissue Res (1979) 0.77
Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study. Vaccine (2011) 0.77
C-fos, c-myc and IL-2R mRNA expression in PHA activated T lymphocytes treated with a monoclonal anti-HLA class I antibody (MAb 01.65). Biochem Int (1990) 0.76
Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells. Experientia (1995) 0.76
Novel diterpenoid diacylglycerols from marine molluscs: potent morphogens and protein kinase C activators. Experientia (1996) 0.76
Fatty acids of subcellular fractions of Saccharomyces cerevisiae during the phases of growth. Ital J Biochem (1969) 0.76
Uracil-DNA glycosylase in meiotic and post meiotic male germ cells of the mouse. Prog Clin Biol Res (1982) 0.76
Identification of a novel protein kinase C inhibitor in microsomes from phytohaemagglutinin activated human peripheral blood mononuclear cells. FEBS Lett (1993) 0.75
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review. J Prev Med Hyg (2011) 0.75
Multiple forms of DNA polymerase from the thermo-acidophilic eubacterium Bacillus acidocaldarius: purification, biochemical characterization and possible biological role. Biochem J (1998) 0.75
Inequalities and health: analysis of a model for the management of Latin American users of an emergency department. J Prev Med Hyg (2008) 0.75
Increased blood lead levels in runners training in urban areas. Arch Environ Health (1994) 0.75